2012
DOI: 10.1177/1076029612448418
|View full text |Cite
|
Sign up to set email alerts
|

Primary thrombophilia in Mexico IX

Abstract: In Mexican mestizo patients, the platelet GP IIIa PL(A1/A2) gene polymorphism does not lead to the SPS phenotype.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 30 publications
0
8
0
Order By: Relevance
“…During a 324-month period, all consecutive mestizo Mexican patients referred to our center by physicians from different parts of the country were prospectively enrolled if they had one of the following clinical markers related to a primary hypercoagulable state [ 6 , 7 , 8 , 9 , 10 , 11 ]: a) thrombosis at age younger than 40 years; b) family history of thrombosis (first-degree relatives); c) recurrent thrombosis without apparent triggering factors; d) thrombosis at uncommon anatomic locations; or e) resistance to conventional antithrombotic therapy. Patients with overt malignancy, puerperium, pregnancy, use of oral contraceptives, or other conditions related to secondary thrombophilia were excluded.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…During a 324-month period, all consecutive mestizo Mexican patients referred to our center by physicians from different parts of the country were prospectively enrolled if they had one of the following clinical markers related to a primary hypercoagulable state [ 6 , 7 , 8 , 9 , 10 , 11 ]: a) thrombosis at age younger than 40 years; b) family history of thrombosis (first-degree relatives); c) recurrent thrombosis without apparent triggering factors; d) thrombosis at uncommon anatomic locations; or e) resistance to conventional antithrombotic therapy. Patients with overt malignancy, puerperium, pregnancy, use of oral contraceptives, or other conditions related to secondary thrombophilia were excluded.…”
Section: Methodsmentioning
confidence: 99%
“…Sticky platelet syndrome (SPS) was first described by Holliday et al [ 1 ] at the 9 th Conference on Stroke and Cerebral Circulation in Arizona in 1983. Since then, we and others have found that SPS is a common cause of arterial and venous thrombosis [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 ]. SPS is the second most common hereditary thrombophilic condition after resistance to activated protein C and the most common thrombophilia associated with arterial thrombosis, with an incidence of 21% [ 3 , 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Sokol et al showed a significantly increased incidence of these GP6 polymorphisms in SPS patients with miscarriages [20]. Furthermore, Ruiz–Argüelles et al analyzed the glycoprotein IIIa PI A1/A2 polymorphism in conjunction with the SPS, but no significant association was found [46]. Sokol et al investigated SPS patients with miscarriages and controls for genetic polymorphism and Gas6/PEAR1 gene polymorphisms could be described [16].…”
Section: Discussionmentioning
confidence: 99%
“…Although there have been multiple studies, to date, it has not been possible to find a genetic alteration that explains this syndrome. Different membrane protein polymorphisms have been studied, such as mutations in GPIIIaPlA A1/A2 and in Gas6 c. 834 + 7G>A, in which no statistically significant difference was found between the groups with SPS and controls [ 17 , 18 ]. However, some polymorphisms of GP6 SNPs have been shown to be present more frequently in cases of SPS [ 19 ].…”
Section: Discussionmentioning
confidence: 99%